⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Cannabigerol (CBG)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-30 — Cannabigerol Enhances Muscle Strength and Performance in Dexamethasone-Treated Mice.: [animal-model] A four-week study in mice with dexamethasone-induced muscle atrophy reported that CBG (10 mg/kg intraperitoneally on training days) combined with resistance exercise improved muscle power output, peak grip strength, and lactate clearance; these findings do not establish benefits in humans or age-related sarcopenia. [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
Cannabigerol Enhances Muscle Strength and Performance in Dexamethasone-Treated Mice.
30-sep-2026
novelty 3
per-area 3
strengthens